Lyle Melenka

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

The Effects of Fluticasone with or without Salmeterol on Systemic Biomarkers of Inflammation in Chronic Obstructive Pulmonary Disease

Don D. Sin, S. F. Paul Man, Darcy D. Marciniuk et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 214 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +17

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling et al. · The Lancet Respiratory Medicine · 2023 · 141 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Lung Health in Sawmill Workers Exposed to Pine and Spruce

Patrick A. Hessel, F. A. Herbert, Lyle Melenka et al. · CHEST Journal · 1995 · 80 citations

Pharmacy, Forestry, Toxicology +14

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

Dave Singh, Christopher E. Brightling, Klaus F. Rabe et al. · The Lancet Respiratory Medicine · 2024 · 64 citations · Full text

Medicine, Internal Medicine, Pharmacology +10